Peposertib, for instance, exhibits enhanced tumor-targeting specificity when combined with RT, as evidenced in a melanoma brain metastasis model where alterations in DNA-PKcs phosphorylation and subcellular localization were observed [161,164]. This evidence concerns the gene PRKDC and neoplasm.